If you want to know Bionaturis Group latest news, here you are our November Newsletter

Imagen Bionaturis Newsletter

IN THIS ISSUE

    • Bionaturis shall evaluate the human application of its lead vaccine against Leishmaniasis

 

    • Bionaturis Group reports H1-2016 Results

 

  • Biobide shows the advantages of zebrafish in three international events in November

Let’s get to know…

Lise Deuilhé, 24 years old, born in Toulouse (France). Chemical Engineer by the Ecole Nationale Supérieure in Rennes.

 

 

Lise Deuilhé

  • -When you were a child, what did you want to be as an adult?
  • I wanted to be a lot of things: a vet, doctor, pilot, teacher, journalist, pianist…
  • -What do you like the most about your job?
  • Learning new things every day and its adaptability to the society needs: it is always progressing.
  • -What are your future challenges?
  • Carrying on my training and working abroad.
  • -Your favourite dish
  • Anyone with chicken or pizzas.
  • -A place
  • Seville, or also places with beaches and sun.
  • -A film
  • ‘Edward Scissorhands’, by Tim Burton.
  • -A historical figure
  • Nelson Mandela, because he is a symbol of the fight for the human rights.
  • -A book
  • ‘Le petit prince’, by Antoine de Saint-Exupéry.
  • -A song
  • ‘Feeling good ‘, by Nina Simone.
  • -What do you usually do in your free time?
  • I usually play sports, mainly judo, but I also like going out with friends and travelling.
  • -You can’t live without…
  • Sun and heat.
  • -How do you imagine the world in 20 years?
  • I think everything will be automatized and Science will be the centre of our daily life in good times and in bad ones.
Lise has been doing a trainee in Bionaturis since September, 2016.

Bionaturis shall evaluate the human application of its lead vaccine against Leishmaniasis

Bionaturis has announced today that it has received a grant by the Spanish Ministry of Economy and Competitiveness – RETOS 2016 call cofounded by FEDER- to evaluate the application in human of its first in class lead vaccine against Leishmaniasis. For this initiative Bionaturis shall partner up with the Lopez Neyra Institute – Spanish National Research Council (CSIC, in Spanish) […] Read more

Bionaturis Group reports H1-2016 Results

The biotech group reported revenue of €2.25 Million for the first half of 2016, an increase of €1.36 Million (or 155%) compared with same period of 2015. EBITDA for the first half of 2016 was €0.65 Million, compared with €-0.37 Million for the first half of 2015, on a reported basis […] Read more

Biobide shows the advantages of zebrafish
in three international events in November

 

Biobide –Bionaturis Group- shows the advantages of zebrafish as animal model in three international events this November. The first one is the VIII Spanish Drug Discovery Network Meeting, which will be held on 3-4th November in Santiago de Compostela; the second one is the SETAC World Congress (on 6-10th November in Orlando, USA); and the third one is the World Preclinical Congress Europe in Lisbon on 14-16th […] Read more

INVESTOR INFO

Relevant info: R&D Incentive from RETOS to BNT005 (Only in Spanish)  

Financial Information 1S-2016 (Only in Spanish) 

Hi, this newsletter contains information about my website. For any question, please contact to info@bionaturis.com
Imagen Boletín Bionaturis Imagen Twitter Bionaturis Imagen Linked In Bionaturis Imagen Flickr Bionaturis Imagen Youtube Bionaturis Imagen Blog Bionaturis
Este e-mail ha sido enviado por *|EMAIL|*¿Por qué me sale esto? No quiero seguir recibiendo este newsletter Actualizar las preferencias de suscripción*|LIST:ADDRESSLINE|**|REWARDS|*